smartbax

About smartbax

smartbax is a biotech company focused on developing innovative antibiotics to combat multi-drug resistant bacteria, aiming to protect global health with a new generation of treatments featuring unprecedented modes of action.

Products & Services

Next-Generation Antibiotics:Antibiotics with novel modes of action targeting unexploited bacterial targets to hinder resistance development. These include first-in-class compounds effective against multi-drug resistant pathogens like MRSA, VRE, and CREB, with the ability to treat biofilms.

Specialties

Development of antibiotics with novel modes of action Targeting multi-drug resistant bacteria Enzyme activation for biofilm treatment Research on Gram-positive and Gram-negative bacteria antibiotics antimicrobial resistance small-molecule drug development small-molecule drugs

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Pre-Series A T: - FT: Pre-Series A	A: 6300000 MR: - FA: €6.3M FAN: 6300000	D: 2026-06-30 FD: 2026-06-30	6 investors
2	RT: Pre-Series A T: - FT: Pre-Series A	A: 5170000 MR: - FA: €4.7 M FAN: 5170000	D: 2025-10-22 FD: 2025-10-22	5 investors
3	RT: Seed T: - FT: Seed	A: 1296000 MR: - FA: €1.2 million FAN: 1296000	D: 2023-05-23 FD: 2023-05-23	2 investors

Pre-Series A Latest

2026-06-30

$6.3M

6 investors (Pro only)

Pre-Series A 2025-10-22

$5.2M

Seed 2023-05-23

$1.3M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

smartbax Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised